Streptozocin
Pronouncation: (STREP-toe-ZOE-sin)Class: Nitrosourea
Trade Names:
Zanosar
- Powder for injection 1 g
Pharmacology
Feedback for Streptozocin
Compare with other drugs. |
Streptozocin is a naturally occurring nitrosourea that contains a glucose moiety not present in the other compounds. The glucose moiety is believed to contribute to reduced myelotoxicity. Streptozocin inhibits DNA synthesis without significantly affecting RNA or protein synthesis in bacterial and mammalian cells. The biochemical mechanism leading to mammalian cell death has not been established but is at least partially caused by DNA alkylation causing intrastrand crosslinks. After rapid IV injection, unchanged drug is rapidly cleared from the plasma (half-life, 35 min).
Pharmacokinetics
Absorption
Streptozocin disappears from blood very quickly.
Distribution
Streptozocin concentrates in liver and kidneys
Metabolism
As much as 20% of the drug (or metabolites containing an N-nitrosourea group) is metabolized and/or excreted by the kidney.
Elimination
As much as 20% of the drug (or metabolites containing an N-nitrosourea group) is metabolized and/or excreted by the kidney.
Indications and Usage
Adult/PediatricSymptomatic or progressive metastatic islet cell carcinoma of the pancreas.
Contraindications
Standard considerations.
Dosage and Administration
Pancreatic Islet Cell CarcinomaAdult
IV 500 mg/m 2 /day for 5 days every 4 to 6 wk; or 1,000 mg/m 2 once a week for the first 2 wk, increased to a max of 1,500 mg/m 2 if necessary. Do not give more than 1,500 mg/m 2 in a single dose because of dose-related nephrotoxicity. Median total dose to maximal response is 4,000 mg/m 2 .
PediatricIV No pediatric dosing information is available.
Adjustment in Renal InsufficiencyAdult
IV If CrCl is more than 50 mL/min, administer 100% of usual dose. If CrCl is 10 to 50 mL/min, administer 75% of usual dose. If CrCl is less than 10 mL/min, administer 50% of usual dose.
Drug Interactions
Nephrotoxic agentsBecause streptozocin is nephrotoxic, do not use in combination with other nephrotoxic agents.
Laboratory Test Interactions
None well documented.
Adverse Reactions
CNS
Confusion, lethargy, depression (observed with 5 day continuous infusion).
GI
Very high potential for nausea and vomiting, diarrhea, jaundice, transient elevation of LFTs, hypoalbuminemia.
Hematologic
Bone marrow suppression, nadir at 7 to 14 days.
Metabolic
Hypoglycemia, usually within 24 hr of the dose.
Renal
Dose-related and cumulative renal tubular damage in 25% to 75% of patients, renal failure, reversible if streptozocin stopped early.
Precautions
WarningsGINausea and vomiting usually begin 1 to 4 hr after administration and last for 24 hr; occasionally requiring discontinuation of drug therapy. Liver dysfunction, hematological changesHave been observed. Renal toxicityRenal toxicity occurs in up to 2/ 3 of all patients treated with streptozocin, as evidenced by azotemia, anuria, hypophosphatemia, glycosuria, and renal tubular acidosis. Such toxicity is dose-related and cumulative and may be severe or fatal. |
Pregnancy
Category C .
Lactation
Undetermined.
Extravasation risk
Local irritation or phlebitis may occur. Refer to your institution specific protocol.
Hypoglycemia
Mild to moderate abnormalities of glucose tolerance have generally been reversible, but insulin shock with hypoglycemia has occurred.
Hydration
Because of renal toxicity, keep the patient well hydrated.
Topical exposure
May pose a carcinogenic hazard following topical exposure if not properly handled.
Patient Information
- Advise patient, family, or caregiver that medication will be prepared and administered by health care provider in a health care setting.
- Review dosing schedule (daily or weekly dose) with patient, family, or caregiver.
- Advise patient, family, or caregiver to immediately report any of the following to the health care provider: decreased urination; fever, chills, or other signs of infection; unusual bleeding or bruising; pain, redness, or swelling at injection site.
- Advise patient, family, or caregiver to report any of the following to the health care provider: persistent nausea, vomiting, diarrhea, or appetite loss; persistent or worsening general body weakness.
- Caution patient that medication may cause confusion, drowsiness, and depression and to use caution when driving or performing other tasks that require mental alertness or coordination.
- Caution women of childbearing potential to avoid becoming pregnant during therapy.
| Link to this page | ![]() |
Printable Version | ![]() |
Email Page | ![]() |
Add to my drug list |
More Streptozocin resources:
Streptozocin - Includes detailed dosage instructions.
Streptozocin Drug Interactions













